Montecito Bank & Trust’s Organon & Co OGN Stock Holding History

Montecito Bank & Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,707	Closed	-$234K	–	261
2022 Q1	$234K	Buy	+6,707	New	+$229K	0.04%	248

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Montecito Bank & Trust's OGN Position: Q2 2022 in Review

Montecito Bank & Trust sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 6,707 shares — an estimated $234K sold.

Montecito Bank & Trust first reported a position in OGN in Q1 2022 and held it in 1 quarter. The position peaked at $234K in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

Montecito Bank & Trust reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
Montecito Bank & Trust sold 6,707 Organon & Co shares in Q2 2022, an estimated $234K.
Montecito Bank & Trust first reported a position in Organon & Co in Q1 2022 and held it in 1 quarter.
Montecito Bank & Trust's Organon & Co position peaked at $234K in Q1 2022.
853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Montecito Bank & Trust's 13F filing for Q2 2022, filed 1 Aug 2022.